21. Duley L., Mahomed K. Magnesium sulphate in eclampsia. Lancet 1998; 351: 1061–1062
22. The Eclampsia Trial Collaborative Group. Which anticonvulsant for woman with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345:1455–1463
23. Elimian A., Verma R., Ogburn P. et al. Magnesium sulfate and neonatal outcomes of preterm neonates. J Matern Fetal Neonatal Med 2002; 12 (2): 118–122
24. El–Sayed Y.Y., Riley E.T., Holbrook R.H. et al. Randomized comparison of intravenous nitroglycerin and magnesium sulfate for treatment of preterm labor. Obstet Gynecol 1999; 93 (1): 79–83
25. Farkouh L.J., Thorp J.A., Jones P.G. et al. Antenatal magnesium exposure and neonatal demise. Am J Obstet Gynecol 2001; 185 (4): 869–872
26. Friedman S.A., Kee–Hak L., Baker C.A., Repke J.T. Phenytoin versus magnesium sulphate in pre–eclampsia: a pilot study. Am J Perinat 1993; 10: 223–238
27. Ganzevoort J.W., Hoogerwaard E.M., van der Post J.A. Hypocalcemic delirium due to magnesium sulphate therapy in a pregnant woman with pre–eclampsia Ned Tijdschr Geneeskd 2002; 146 (31): 1453–1456
28. Grether J.K., Hoogstrate J., Selvin S., Nelson K.B. Magnesium sulfate tocolysis and risk of neonatal death. Am J Obstet Gynecol 1998; 178 (1) :1–6
29. Grether J.K., Hoogstrate J., Walsh–Greene E., Nelson K.B. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Am J Obstet Gynecol 2000; 183 (3): 717–725
30. Gude N.M., Stevenson J.L., Moses E.K., King R.G. Magnesium regulates hypoxia–stimulated apoptosis in the human placenta. Clin Sci (Lond) 2000; 98 (4): 375–380
31. Haghighi L. Prevention of preterm delivery: nifedipine or magnesium sulfate. Int J Gynaecol Obstet 1999; 66 (3): 297–298
32. Halhali A., Wimalawansa S.J., Berentsen V. et al. Calcitonin gene– and parathyroid hormone–related peptides in preeclampsia: effects of magnesium sulfate. Obstet Gynecol 2001; 97 (6): 893–897
33. Hallak M., Martinez–Poyer J., Kruger M.L. The effect of magnesium sulfate on fetal heart rate parameters: A randomized, placebo–controlled trial. Am J Obstet Gynecol 1999; 181 (5): 1122–1127
34. Hamersley S.L., Landy H.J., O’Sullivan M.J. Fetal bradycardia secondary to magnesium sulfate therapy for preterm labor. A case report. Reprod Med 1998; 43 (3): 206–210
35. Hennessy A., Hill I. A case of maternal bradycardia at therapeutic doses of magnesium sulphate in preeclampsia. Aust N Z J Obstet Gynaecol 1999; 39 (2): 256–257
36. Herschel M., Mittendorf R.J. Tocolytic magnesium sulfate toxicity and unexpected neonatal death. Perinatol 2001; 21 (4): 261–262
37. Jacob S., Gopalakrishnan K., Lalitha K. Standartised clinical trial of magnesium sulphate regime in comparison with M.K.K. Menon’s lytic coctail regime in the management of eclampsia. Proceedings of the 27th British Congress of Obstetrics and Gynaecology; 4–7 July 1995; Dublin, 1995: 303
38. Jaspers V., Spatling L., Fallenstein F., Quakernack K. Magnesium, calzium, hamoglobin, hamatokrit, ostriol und HPL unter magnesiumsubstitution in der schwangerschaft. Geburtshilfe–Frauenheilkd 1990; 50: 628–633
39. Kamitomo M., Sameshima H., Ikenoue T., Nishibatake M.J. Fetal cardiovascular function during prolonged magnesium sulfate tocolysis. Perinat Med 2000; 28 (5): 377–382
40. Kantas E., Cetin A., Kaya T., Cetin M. Effect of magnesium sulfate, isradipine, and ritodrine on contractions of myometrium: pregnant human and rat. Acta Obstet Gynecol Scand 2002; 81 (9): 825–830
41. Katz V.L., Farmer R.M. Controversies in tocolytic therapy. Clin Obstet Gynecol 1999; 42 (4): 802–819
42. Kisters K., Barenbrock M., Louwen F. et al. Membrane, intracellular, and plasma magnesium and calcium concentrations in preeclampsia Am J Hypertens 2000; 13 (7): 765–769
43. Kovacs L.M., Molnar B.G., Huhn E., Bodis L. Magnesiumsubstitution in der Schwangerschaft: eine prospektiye, randomisierte doppelblindstudie. Geburtsh u Frauenheilk 1988; 48: 595–600
44. Kuno N., Ishikawa K Serum creatine phosphokinase elevation in patients treated with intravenous magnesium sulfate. Int J Gynaecol Obstet 2002; 76 (3): 257–266
45. Lemancewicz A., Laudanska H., Laudanski T. et al. Permeability of fetal membranes to calcium and magnesium: possible role in preterm labour. Hum Reprod 2000; 15 (9): 2018–2222
46. Li S., Tian H. Oral low–dose magnesium gluconate preventing pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 1997; 32 (10): 613–615
47. Lu J.F., Nightingale C.H. Magnesium sulfate in eclampsia and pre–eclampsia: pharmacokinetic principles. Clin Pharmacokinet 2000; 38 (4): 305–314
48. Lurie S., Rotmensch S., Feldman N., Glezerman M. Breast engorgement and galactorrhea during magnesium sulfate treatment of preterm labor. Am J Perinatol 2002; 19 (5): 239–240
49. Macones G.A., Sehdev H.M., Berlin M. et al. Evidence for magnesium sulfate as a tocolytic agent. Obstet Gynecol Surv 1997; 52 (10): 652–658
50. The Magpie Trial Collaboration Group. Do women with pre–eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo–controlled trial. Lancet 2002; 359 (9321): 1877–1890
51. Manyemba J. Magnesium sulphate for eclampsia: putting the evidence into clinical practice. Cent Afr J Med 2000; 46 (6): 166–169
52. Matsuda Y., Kouno S., Hiroyama Y. et al. Intrauterine infection, magnesium sulfate exposure and cerebral palsy in infants born between 26 and 30 weeks of gestation. Eur J Obstet Gynecol Reprod Biol 2000; 91 (2): 159–164
53. Mittendorf R., Pryde P.G. An overview of the possible relationship between antenatal pharmacologic magnesium and cerebral palsy. Med J Perinat 2000; 28 (4): 286–293
54. Mittendorf R., Dambrosia J., Pryde P.G. et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002; 186 (6): 1111–1118
55. Mittendorf R., Dambrosia J., Dammann O.J. et al. Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage. Pediatr 2002; 140 (5): 540–546
56. Morisaki H., Yamamoto S., Morita Y. J. et al. Hypermagnesemia–induced cardiopulmonary arrest before induction of anesthesia for emergency cesarean section. Clin Anesth 2000; 12 (3): 224–226
57. Morgan P.J., Kung R., Tarshis J. Nitroglycerin as a uterine relaxant: a systematic review. J Obstet Gynaecol Can 2002; 24 (5): 403–409
58. Morrison E.H. Common peripartum emergencies. Am Fam Physician 1998; 58 (7): 1593–1604
59. Naidu S., Payne A.J., Moodley J. Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound. Br. J. Obstet. Gynaecol. 1996; 103: 111–116
60. Ohta N., Tsukahara H., Yamashita N. et al. Infantile renal dysfunction associated with intrauterine exposure to ritodrine and magnesium sulfate. Nephron 2002; 91 (2): 352–353
61. Phillippe M. Cellular mechanisms underlying magnesium sulfate inhibition of phasic myometrial contractions. Biochem Biophys Res Commun 1998; 252 (2): 502–507
62. Pryde P.G., Besinger R.E., Gianopoulos J.G., Mittendorf R. Adverse and beneficial effects of tocolytic therapy. Semin Perinatol 2001; 25 (5): 316–340
63. Qi Q., Li W., Wang Z. Magnesium and calcium concentration of peripheral serum and mononuclear cells in patients with pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 1997; 32 (1): 15–18
64. Raman N.V., Rao C.A. Magnesium sulfate as an anticonvulsant in eclampsia. Int J Gynaecol Obstet 1995; 49 (3): 289–298
65. Rantonen T., Kaapa P., Jalonen J. et al. Antenatal magnesium sulphate exposure is associated with prolonged parathyroid hormone suppression in preterm neonates. Acta Paediatr 2001; 90 (3): 278–281
66. Riaz M., Porat R., Brodsky N.L., Hurt H. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study. J Perinatol 1998; 18 (6): 449–454
67. Ricci J.M., Hariharan S., Helfgott A. et al. Oral tocolysis with magnesium chloride: a randomized controlled prospective clinical trial. Am J Obstet Gynecol 1991; 1654: 603–610
68. Ridgway L.E., Muise K., Wright J. W. et al. A prospective randomized comparison of oral terbutaline and magnesium oxide for the maintenance of tocolysis. Am J Obstet Gynecol 1990; 163: 879–882
69. Roffe C., Sills S., Crome P., Jones P. Randomised, cross–over, placebo controlled trial of magnesium citrate in the treatment of chronic persistent leg cramps. Med Sci Monit 2002; 8 (5): 326–330
70. Rudnicki M., Frolich A., Pilsgaard K. et al. Comparison of magnesium and methyldopa for the control of blood pressure in pregnancies complicated with hypertension. Gynecol Obstet Invest 2000; 49 (4): 231–235
71. Sameshima H., Ikenoue T. Long–term magnesium sulfate treatment as protection against hypoxic–ischemic brain injury in seven–day–old rats. Am J Obstet Gynecol 2001; 184 (2): 185–190
72. Sawhney H., Vasishta K., Rani K. Comparison of lytic cocktail and magnesium sulphate regimens in eclampsia: a retrospective analysis. J Obstet Gynaecol Res 1998; 24 (4): 261–266
73. Sawhney H., Sawhney I.M., Mandal R. et al. Efficacy of magnesium sulphate and phenytoin in the management of eclampsia. J Obstet Gynaecol Res 1999; 25 (5): 333–338
74. Sawhney H., Aggarwal N., Biswas R. et al. Maternal mortality associated with eclampsia and severe preeclampsia of pregnancy. J Obstet Gynaecol Res 2000; 26 (5): 351–356
75. Schorr S.J., Ascarelli M.H., Rust O.A. et al. A comparative study of ketorolac (Toradol) and magnesium sulfate for arrest of preterm labor. South Med J 1998; 91 (11): 1028–1032
76. Scudiero R., Khoshnood B., Pryde P.G. et al. Perinatal death and tocolytic magnesium sulfate. Obstet Gynecol 2000; 96 (2): 178–182
77. Semczuk M, Semczuk–Sikora A. New data on toxic metal intoxication (Cd, Pb, and Hg in particular) and Mg status during pregnancy. Med Sci Monit 2001; 7 (2): 332–340
78. Shamsuddin L., Rouf S., Khan J.H. et al. Magnesium sulphate versus diazepam in the management of eclampsia. Bangladesh Med Res Counc Bull 1998; 24: 43–48
79. Sibai B.M., Villar M.A., Bary E. Magnesium supplementation during pregnancy: a double–blind randomized controlled clinical trial. Am J Obstet Gynecol 1989; 161: 115–119
80. Surichamorn P. The efficacy of terbutaline and magnesium sulfate in the management of preterm labor. J Med Assoc Thai 2001; 84 (1): 98–104
81. Tan Y., Zhang W., Lu B. Treatment of intrauterine growth retardation with magnesium sulfate. Zhonghua Fu Chan Ke Za Zhi 2000; 35 (11): 664–666
82. Terrone D.A., Rinehart B.K., Kimmel E.S. et al. A prospective, randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis. Am J Obstet Gynecol 2000; 182 (6): 1477–1482
83. Thomas S.V. Neurological aspects of eclampsia. J Neurol Sci 1998; 155 (1): 37–43
84. Walsh S.W., Romney A.D., Wang Y., Walsh M.D. Magnesium sulfate attenuates peroxide–induced vasoconstriction in the human placenta. Am J Obstet Gynecol 1998; 178 (1): 7–12
85. Witlin A.G., Sibai B.M. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998; 92 (5): 883–889
86. Young G.L., Jewell D. Interventions for leg cramps in pregnancy. Cochrane Database Syst Rev 2002; (1): CD000121
8-09-2015, 18:56